UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000038076 |
|---|---|
| Receipt number | R000043395 |
| Scientific Title | Measurement of radiation dose of the patient with radiophotoluminescence dosimeter in neuro angiography |
| Date of disclosure of the study information | 2020/04/01 |
| Last modified on | 2025/03/27 07:15:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Measurement of radiation dose of the patient in neuro angiography
Acronym
Measurement of radiation dose of the patient in neuro angiography
Scientific Title
Measurement of radiation dose of the patient with radiophotoluminescence dosimeter in neuro angiography
Scientific Title:Acronym
Measurement of radiation dose of the patient with radiophotoluminescence dosimeter in neuro angiography
Region
| Japan |
Condition
Condition
cerebral aneurysm, cerebral arteriovenous malformation, dural cerebral arteriovenous fistula etc.
Classification by specialty
| Radiology | Neurosurgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Estimation of radiation dose of the patients in cases of neurointerventional radiology
Basic objectives2
Others
Basic objectives -Others
Estimation of skin doses and bilatrral lens doses
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Estimation of skin doses and lens doses performed neurointerventional radiology
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
Setting of exclusive dosimerty cap
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Patients scheduled to undergo neurointerventional radiology
2) Age is 20 years or older
3) Any gender
Key exclusion criteria
Pediatric patient
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Watarou |
| Middle name | |
| Last name | Tsuruta |
Organization
Toranomon Hospital
Division name
Department of Endovascular Neurosurgery
Zip code
105-8470
Address
2-2-2 Toranomon, Minato, Tokyo
TEL
03-3588-1111
wataro@cf6.so-net.ne.jp
Public contact
Name of contact person
| 1st name | Satoru |
| Middle name | |
| Last name | Kawauchi |
Organization
Toranomon Hospital
Division name
Department of Radiology
Zip code
105-8470
Address
2-2-2 Toranomon, Minato, Tokyo
TEL
03-3588-1111
Homepage URL
shibaken.shatle@kjd.biglobe.ne.jp
Sponsor or person
Institute
Toranomon Hospital
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Toranomon Hospital
Address
2-2-2 Toranomon, Minato, Tokyo
Tel
03-3588-1111
chiken-jim2@toranomon.gr.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Suspended
Date of protocol fixation
| 2019 | Year | 09 | Month | 21 | Day |
Date of IRB
| 2020 | Year | 05 | Month | 14 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 15 | Day |
Last follow-up date
| 2025 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
| 2025 | Year | 09 | Month | 30 | Day |
Date trial data considered complete
| 2025 | Year | 09 | Month | 30 | Day |
Date analysis concluded
| 2026 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2019 | Year | 09 | Month | 21 | Day |
Last modified on
| 2025 | Year | 03 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043395
